CS MCKEE LP historic quarter change: USA Everything Else, Reduced
In partnership units, exchange-traded notes and anything else (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, CS MCKEE LP opened 4 positions, added to 0, reduced 22 and sold out of 4.
- Q3 2016: Stock ALLERGAN PLC; Country of operation —; Class SHARES; Shares before 151,425.
- Q3 2016: Stock ENDURANCE SPECIALTY; Country of operation —; Class SHARES; Shares before 19,650.
- Q2 2016: Stock ALLERGAN PLC; Country of operation —; Class SHARES; Shares before 173,902.
- Q1 2016: Stock ALLERGAN PLC; Country of operation —; Class SHARES; Shares before 191,861.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 728575), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-15); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-13); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-12); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-14); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 1999-03-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | ALLERGAN PLC
CUSIP G0177J108 | | SHARES | 151,425 | 73,542 | -77,883 | $34,993,000 | $16,937,000 | -$18,056,000 | 2016-11-15 |
|---|
| Q3 2016 | ENDURANCE SPECIALTY
CUSIP G30397106 | | SHARES | 19,650 | 17,300 | -2,350 | $1,320,000 | $1,132,000 | -$188,000 | 2016-11-15 |
|---|
| Q2 2016 | ALLERGAN PLC
CUSIP G0177J108 | | SHARES | 173,902 | 151,425 | -22,477 | $46,611,000 | $34,993,000 | -$11,618,000 | 2016-08-15 |
|---|
| Q1 2016 | ALLERGAN PLC
CUSIP G0177J108 | | SHARES | 191,861 | 173,902 | -17,959 | $59,957,000 | $46,611,000 | -$13,346,000 | 2016-05-16 |
|---|
| Q4 2015 | ALLERGAN PLC
CUSIP G0177J108 | | SHARES | 202,016 | 191,861 | -10,155 | $54,910,000 | $59,957,000 | +$5,047,000 | 2016-02-12 |
|---|
| Q3 2015 | ALLERGAN
CUSIP G0177J108 | | SHARES | 217,150 | 202,016 | -15,134 | $65,896,000 | $54,910,000 | -$10,986,000 | 2015-11-13 |
|---|
| Q3 2015 | ENDURANCE SPECIALTY
CUSIP G30397106 | | SHARES | 90,855 | 81,715 | -9,140 | $5,969,000 | $4,987,000 | -$982,000 | 2015-11-13 |
|---|
| Q2 2015 | ENDURANCE SPECIALTY
CUSIP G30397106 | | SHARES | 95,285 | 90,855 | -4,430 | $5,826,000 | $5,969,000 | +$143,000 | 2015-08-14 |
|---|
| Q1 2015 | ACTAVIS PLC
CUSIP G0083B108 | | SHARES | 252,827 | 232,928 | -19,899 | $65,080,000 | $69,324,000 | +$4,244,000 | 2015-05-15 |
|---|
| Q1 2015 | ENDURANCE SPECIALTY
CUSIP G30397106 | | SHARES | 109,095 | 95,285 | -13,810 | $6,528,000 | $5,826,000 | -$702,000 | 2015-05-15 |
|---|
| Q4 2014 | ENDURANCE SPECIALTY
CUSIP G30397106 | | SHARES | 164,600 | 109,095 | -55,505 | $9,083,000 | $6,528,000 | -$2,555,000 | 2015-02-13 |
|---|
| Q4 2014 | ACTAVIS PLC
CUSIP G0083B108 | | SHARES | 267,654 | 252,827 | -14,827 | $64,580,000 | $65,080,000 | +$500,000 | 2015-02-13 |
|---|
| Q3 2014 | ACTAVIS PLC
CUSIP G0083B108 | | SHARES | 291,172 | 267,654 | -23,518 | $61,369,000 | $64,580,000 | +$3,211,000 | 2014-11-14 |
|---|
| Q2 2014 | COVIDIEN PLC
CUSIP G2554F113 | | SHARES | 259,135 | 245,648 | -13,487 | $19,088,000 | $22,153,000 | +$3,065,000 | 2014-08-12 |
|---|
| Q2 2014 | ACTAVIS PLC
CUSIP G0083B108 | | SHARES | 300,567 | 291,172 | -9,395 | $61,872,000 | $61,369,000 | -$503,000 | 2014-08-12 |
|---|
| Q1 2014 | ACTAVIS PLC
CUSIP G0083B108 | | SHARES | 349,008 | 300,567 | -48,441 | $58,633,000 | $61,872,000 | +$3,239,000 | 2014-05-14 |
|---|
| Q1 2014 | ENDURANCE SPECIALTY
CUSIP G30397106 | | SHARES | 270,470 | 241,740 | -28,730 | $15,868,000 | $13,013,000 | -$2,855,000 | 2014-05-14 |
|---|
| Q1 2014 | COVIDIEN PLC
CUSIP G2554F113 | | SHARES | 273,695 | 259,135 | -14,560 | $18,639,000 | $19,088,000 | +$449,000 | 2014-05-14 |
|---|
| Q4 2013 | ENDURANCE SPECIALTY
CUSIP G30397106 | | SHARES | 445,650 | 270,470 | -175,180 | $23,940,000 | $15,868,000 | -$8,072,000 | 2014-02-14 |
|---|
| Q4 2013 | COVIDIEN PLC
CUSIP G2554F113 | | SHARES | 286,940 | 273,695 | -13,245 | $17,486,000 | $18,639,000 | +$1,153,000 | 2014-02-14 |
|---|
| Q3 2013 | COVIDIEN PLC
CUSIP G2554F113 | | SHARES | 293,840 | 286,940 | -6,900 | $18,465,000 | $17,486,000 | -$979,000 | 2013-11-14 |
|---|
| Q3 2013 | ENDURANCE SPECIALTY
CUSIP G30397106 | | SHARES | 474,050 | 445,650 | -28,400 | $24,390,000 | $23,940,000 | -$450,000 | 2013-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |